Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1164508 BOSTON, MA

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$245,478,344
+$112,915,727 QoQ
Shares Held
393,685
+129.5% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#37
of 1,327 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. REGN ranks #3 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
393,685 $245,478,344

All Filings in REGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,478,344 393,685
2026-03-31 $132,562,617 171,571
2025-12-31 $150,279,229 194,695
2025-09-30 $108,284,205 192,584
2025-06-30 $3,183,075 6,063
2023-09-30 $1,861,535 2,262
2023-06-30 $1,625,337 2,262
2022-12-31 $1,198,394 1,661
2022-09-30 $692,314 1,005
2022-06-30 $105,541,532 178,542
2022-03-31 $25,298,867 36,223
2021-12-31 $2,913,833 4,614
2020-12-31 $338,177 700
2020-09-30 $6,829,316 12,200